Jurnale medicale [no title]
This issue provides a clinical overview of sarcoidosis focusing on prevention, diagnosis, treatment, practice improvement, and patient information. Readers can complete the accompanying CME quiz for 1.5 credits.
Only ACP members and individual subscribers can access the electronic features of In themai mult [no title]
Identifying risk factors for breast cancer specific to women in their 40s could inform screening decisions.
To determine what factors increase risk for breast cancer in women aged 40 to 49 years and the magnitude of risk for each factor.
MEDLINE (January 1996 to
Circulating concentrations of 25-hydroxyvitamin D [25-(OH)D] are used to define vitamin D deficiency. Current clinical 25-(OH)D targets based on associations with intermediate markers of bone metabolism may not reflect optimal levels for other chronic diseases and do not account for know
Timing of initiation of screening for breast cancer is controversial in the United States.
To determine the threshold relative risk (RR) at which the harm–benefit ratio of screening women aged 40 to 49 years equals that of biennial screening for women aged 50 to 74 years.
Despite recent improvements in survival after acute myocardial infarction (AMI), U.S. hospitals vary 2-fold in their 30-day risk-standardized mortality rates (RSMRs). Nevertheless, information is limited on hospital-level factors that may be associated with RSMRs.
Context It is unknown whether a history of depression, anxiety disorders, or comorbid depression and anxiety affects subsequent health-related quality of life (HRQOL) during midlife in women when vasomotor symptoms (VMS) and sleep disturbance commonly disrupt QOL.
Objectives To evaluate whether prmai mult [no title]
Context Depression and dementia are common in older adults and often co-occur, but it is unclear whether depression is an etiologic risk factor for dementia.
Objective To clarify the timing and nature of the association between depression and dementia.
Design We examined depressive symptoms assesmai mult [no title]
Context Purpose in life is associated with a substantially reduced risk of Alzheimer disease (AD), but the neurobiologic basis of this protective effect remains unknown.
Objective To test the hypothesis that purpose in life reduces the deleterious effects of AD pathologic changes on cognition in amai mult [no title]